vitrobiopharma2024年價(jià)格表
Vitro Biopharma成立于1986年3月31日,最初注冊(cè)為Imperial管理公司。1986年12月17日與科羅拉多州的Labtek, Inc.合并,更名為L(zhǎng)abtek, Inc.,并于1987年2月6日更名為Vitro Diagnostics, Inc.,最終在2021年2月3日更名為Vitro Biopharma, Inc.
公司最初從事制造和銷(xiāo)售用于診斷應(yīng)用的純化抗原,后來(lái)轉(zhuǎn)型專(zhuān)注于開(kāi)發(fā)治療產(chǎn)品、干細(xì)胞技術(shù)、專(zhuān)li組合和專(zhuān)有技術(shù),以及用于自身免疫性疾病和炎癥性疾病過(guò)程的細(xì)胞系和干細(xì)胞研究。
Vitro Biopharma正在開(kāi)發(fā)新的細(xì)胞治療候選藥物,以滿(mǎn)足大量未得到滿(mǎn)足的醫(yī)療需求。在美國(guó),公司已獲得FDA的兩項(xiàng)IND申請(qǐng)授權(quán),以評(píng)估AlloRx干細(xì)胞療法在皮特霍普金斯綜合征(PTHS)和SARS-CoV-2急性后遺癥(PASC,即Long C0VID)中的安全性和有效性,并預(yù)計(jì)在2022年底或2023年初開(kāi)始這些試驗(yàn)。
特別告知:為保證產(chǎn)品質(zhì)量與良好性能,所以在購(gòu)買(mǎi)相應(yīng)產(chǎn)品的同時(shí)我司會(huì)收取一定量的運(yùn)輸費(fèi)用?。?!本次報(bào)價(jià)有效時(shí)間為2024年4月30日---2024年12月20日。
貨號(hào) | 品名 | 規(guī)格 | 價(jià)格 | 品牌 | 貨期 | 價(jià)格來(lái)源 |
CAF07-AD | Human Lung Adenocarcinoma CAFs, 1,000,000 cells, cryopreserved | 1,000,000cells | 17985.24 | vitrobiopharma | 4-6周 | 上海起發(fā) |
CAF05 | Human Colorectal Adenocarcinoma CAFs, 1,000,000 cells cryopreserved | 1,000,000cells | 21044.4 | vitrobiopharma | 4-6周 | 上海起發(fā) |
PC00B1 | Low-Serum, VitroPlus III, Complete Medium for primary cell cultures, 500 ml | 500ml | 4029.48 | vitrobiopharma | 4-6周 | 上海起發(fā) |
PC00B2 | MSC-GRO™ VitroPlus III Serum-Free, Xeno-Free Complete Medium | 500ml | 4242.42 | vitrobiopharma | 4-6周 | 上海起發(fā) |
PC00B3 | MSC-GRO™ VitroPlus III Serum-Free Medium | 500ml | 3914.82 | vitrobiopharma | 4-6周 | 上海起發(fā) |
PC00B5 | Maintenance medium pancreatic stellate CAFs | 500ml | 4095 | vitrobiopharma | 4-6周 | 上海起發(fā) |
SC00B1 | Low Serum Complete Humand Mesenchymal Stem Cell Medium, 500 ml | 500ml | 3822 | vitrobiopharma | 4-6周 | 上海起發(fā) |
SC00A1 | Human Umbilical Cord Mesenchymal Stem Cells, 500,000 cryopreserved | 500,000cells | 12874.68 | vitrobiopharma | 4-6周 | 上海起發(fā) |
SC00A5 | Human pancreatic primary fibroblast cell line | 500,000cells | 13650 | vitrobiopharma | 4-6周 | 上海起發(fā) |
SC00AD1 | Human Adipose Mesenchymal Stem Cells, 500,000 cryopreserved | 500,000cells | 12874.68 | vitrobiopharma | 4-6周 | 上海起發(fā) |
CAF01 | Human Endometrial Adenocarcinoma CAFs, 1,000,000 cyropreserved | 1,000,000cells | 17674.02 | vitrobiopharma | 4-6周 | 上海起發(fā) |
CAF02 | Human Ovarian Serous Tumor CAFs, 1,000,000 cells cryopreserved | 1,000,000cells | 17674.02 | vitrobiopharma | 4-6周 | 上海起發(fā) |
CAF03 | Human Glioblastoma CAFs, 1,000,000 cells cryopreserved | 1,000,000cells | 32432.4 | vitrobiopharma | 4-6周 | 上海起發(fā) |
CAF04 | Renal Cancer Associated Fibroblasts, 1,000,000 Cells, cryopreserved | 1,000,000cells | 21200.4 | vitrobiopharma | 4-6周 | 上海起發(fā) |
CAF06 | Human Breast Cancer Associated Fibroblast, 1 million cells, cryopreserved | 1,000,000cells | 38469.6 | vitrobiopharma | 4-6周 | 上海起發(fā) |
CAF07S | Human Lung Squamous CAFs, 1,000,000 cells cryopreserved | 1,000,000cells | 21411 | vitrobiopharma | 4-6周 | 上海起發(fā) |
CAF08 | Human Pancreatic Stellate CAFs, 1,000,000, cyropreserved | 1,000,000cells | 32432.4 | vitrobiopharma | 4-6周 | 上海起發(fā) |
CAF09 | Human Melanoma CAFs, 1,000,000 cells cryopreserved | 1,000,000cells | 21200.4 | vitrobiopharma | 4-6周 | 上海起發(fā) |
CAF10 | Prostate Cancer Associated Fibroblasts, 1,000,000 Cells, cryopreserved | 1,000,000cells | 21044.4 | vitrobiopharma | 4-6周 | 上海起發(fā) |
CAF11 | Gastric Cancer Associated Fibroblasts, 1,000,000 Cells, cryopreserved | 1,000,000cells | 21044.4 | vitrobiopharma | 4-6周 | 上海起發(fā) |
C05DON | Normal Colon Fibroblasts 1,000,000 cells per vial. | 1,000,000cells | 13650 | vitrobiopharma | 4-6周 | 上海起發(fā) |
C07ADDON | Normal Lung Fibroblasts 1,000,000 cells per vial. | 1,000,000cells | 13650 | vitrobiopharma | 4-6周 | 上海起發(fā) |
SC00P1 | Human Placental Mesenchymal Stem Cells, 500,000 cryopreserved | 500,000cells | 12874.68 | vitrobiopharma | 4-6周 | 上海起發(fā) |
(*此為部分產(chǎn)品價(jià)格完整價(jià)格請(qǐng)下載文件)
關(guān)鍵詞:vitrobiopharma、細(xì)胞療法、AlloRx干細(xì)胞療法、CAF07-AD、CAF05
電話(huà)
QQ咨詢(xún)
4006551678